The fact that MPTP causes parkinsonism in humans is a major incentive for using this toxin to study PD pathogenesis and, at the same time, the reason why safety measures must be so rigorous. The three ...
More than three decades ago, scientists discovered that a chemical found in a synthetic opioid, MPTP, induced the onset of a form of Parkinson's disease. In a new study led by scientists from the ...
Until five years ago, scientists investigating Parkinson’s disease were frustrated in their attempts to unravel the biochemical mechanism of this debilitating disease. Lacking an animal model, they ...
Opening of the mitochondrial permeability transition pore (MPTP) has been shown to be key to the development of experimental acute pancreatitis. The findings pinpoint MPTP as a potential new drug ...
The MPTP is a pore generated within the mitochondrial inner membrane, which dissipates the membrane potential needed to generate ATP. If prolonged opening occurs, a cell dependent on mitochondrial ATP ...
NRG Therapeutics Ltd. has been awarded a grant from Target ALS Foundation to support its discovery program for a treatment for amyotrophic lateral sclerosis (ALS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results